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Evaluation of American Indian Health Service
Training in Pain Management and Opioid Substance
Use Disorder
Joanna G. Katzman, MD, MSPH, Chris Fore, PhD, Snehal Bhatt, MD, Nina Greenberg, MS, Julie Grifﬁn Salvador, PhD, George C. Comerci, MD,
Christopher Camarata, MD, Lisa Marr, MD, Rebecca Monette, BS, Sanjeev Arora, MD, MACP, Andrea Bradford, MSc, Denise Taylor, MD, Jenny
Dillow, MD, and Susan Karol, MD
We examined the beneﬁts of a collaboration between the Indian Health
Service and an academic medical center to address the high rates of
unintentional drug overdose in American Indians/Alaska Natives.
In January 2015, the Indian Health Service became the ﬁrst
federal agency to mandate training in pain and opioid substance
use disorder for all prescribing clinicians. More than 1300 Indian
Health Service clinicians were trained in 7 possible 5-hour
courses speciﬁc to pain and addiction.
We noted positive changes in pre- and postcourse knowledge, self-efﬁcacy, and attitudes as well as thematic responses
showing the trainings to be comprehensive, interactive, and convenient. (Am J Public Health. 2016;106:1427–1429. doi:10.2105/
AJPH.2016.303193)

T

he number of prescription
opioid overdose deaths has
increased by 4 times between 1999
and 2011 and continues to exceed
the number of deaths owing to
heroin and other illicit drugs.1 In
parallel, the Institute of Medicine
estimates that 100 million Americans suffer from chronic pain.2 The
costs of chronic pain care and drug
overdose, lost workplace productivity, and societal burdens involve billions of dollars each year
and exceed the costs owing to all
other medical conditions.2 Primary
care clinicians treat the majority of
patients suffering from pain and
addiction, yet clinicians prescribing
controlled substances often lack the
conﬁdence and knowledge to effectively manage chronic pain.3
The rate of people aged 12
years and older initiating opioid
analgesics for nonmedical use
continues to grow, with a US
average growth rate of 4.2% in
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2015. This rate is higher for
speciﬁc populations: Hispanics
at 4.3% and American Indians/
Alaska Natives (AI/AN) at 6.9%.1
To address these challenges, on
January 15, 2015 the Indian
Health Service (IHS) mandated
that prescribing clinicians be
trained in pain and opioid substance use disorder. A presidential
memorandum—“Addressing
Prescription Drug Abuse and
Heroin Use”—followed on
October 21, 2015, that requires
that all prescribing clinicians in
federal facilities obtain continuing education, including casebased courses (Figure A, available
as a supplement to the online
version of this article at http://
www.ajph.org).4

BACKGROUND
The IHS is an agency of the
US Department of Health and

Human Services tasked with
providing health care to AI/AN.
In January 2015, IHS deployed
5-hour pain and addiction
training.
These virtual educational
sessions, sponsored in collaboration with the IHS Telebehavioral
Center of Excellence, were
grounded on the mandated State
of New Mexico continuing
medical education training
initiated in 2012.5

THE CONTINUING
MEDICAL EDUCATION
COURSE
We designed an IHS continuing medical education course
to educate prescribing clinicians
on appropriate pain management
and safe opioid prescribing.
Course faculty included the

facilitators of the IHS Pain and
Addiction TeleECHO Clinic as
well as faculty from the University of New Mexico Pain
Center and ECHO (Extension
for Community Healthcare
Outcomes) Pain. Clinicians
received 5 hours of no-cost
continuing medical education
and continuing education
credits.
Didactics included the following: “Overview of Public
Health Crises of Pain and Drug
Overdose Deaths,” “Safe Opioid
Prescribing,” “Use of NonOpioid Medications in Pain
Management,” “Pediatric/
Adolescent Pain Management,”
“Opioid Substance Use Disorder/
Screening,” “Federal Regulations Pertaining to Opioid Prescribing,” and 2 case vignettes
“Controlled Substance Agreement” and “Comorbid Pain/
Psychiatric Condition.”
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METHODS
The intervention included the
study of changes in knowledge,
conﬁdence, and attitudes among
participants. Our short-term
objective was to evaluate changes
in course participant knowledge,
self-efﬁcacy, and attitudes to
demonstrate capacity building,
especially among frontline primary care clinicians. Our
longer-term objective was to
consider the association between
speciﬁc educational interventions
and their potential applications for federal and state educational efforts. Our broader
public health goal was to achieve
a reduction in unintentional
prescription opioid and heroin
deaths among AI/AN
populations.
The informed consent
process that we employed reﬂects
the voluntary and anonymous
nature of the study survey.
Before and after the course, clinicians completed 3 surveys, each
with 12 items: a multiple choice
pain and opioid knowledge
questionnaire, a self-efﬁcacy
survey, and an attitude survey.6
Following the course, we
asked participants 2 open-ended
qualitative questions to inform
future training. We downloaded the written participant
responses into NVivo qualitative software version 10 (QSR
International, Burlington,
MA), and we open coded them
to identify the range of responses and emerging themes.
We grouped these into
broader overarching themes
using a thematic analysis
approach. 7

RESULTS
Survey results comparing preand postcourse scores demonstrated a positive change in the
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knowledge, self-efﬁcacy, and
12-item attitude surveys. We
found signiﬁcant improvement
(P < .001) in knowledge, selfefﬁcacy, and attitudes as demonstrated by answers to surveys
taken before compared with
answers to surveys taken immediately after the course. The
knowledge questions included
questions on screening for opioid
substance use disorder, naloxone
as a harm reduction measure for
opioid overdose, and the use of
nonopioid medications (Table 1).
We offered the courses on 7
dates, and 1315 clinicians across
the country attended them. We
received consent from 1079 clinicians with matching pre–post
surveys (82%) to participate in the
research study, with 92% coming
from IHS, tribal, or urban AI/
AN programs. More than 90% of
the interprofessional group of
clinicians attending the course
had prescriptive authority (Table
A, available as a supplement to
the online version of this article at
http://www.ajph.org).
Answers to the qualitative
questions illustrate the 5 most
common themes that developed.
Of the 1079 participants, there
were 909 responses to question 1
and 818 responses to question 2.
Answers to question 1 showed
that participants found the survey
to be useful, comprehensive,
interactive, well presented, and in
a convenient web-based format.
In response to question 2, participants suggested that training
sessions be shorter, more frequent, and adaptable; include
more details on pain medications;
and resolve some technical issues
(Figure B, available as a supplement to the online version of this
article at http://www.ajph.org).
To cover the vast geographic
spread of the IHS system (from
Alaska to Maine) and to minimize the impact on patient care,
we conducted this training

Peer Reviewed

Katzman et al.

TABLE 1—US Indian Health Service Training in Pain Management
and Opioid Substance Use Disorder—Pre–Post Knowledge, SelfEfﬁcacy, and Attitudes: Indian Health Service Telebehavioral Center
of Excellence Virtual Training, January–June 2015
Survey: Measure

Precourse Mean Postcourse Mean Difference in Means (SD)

Knowledge:
Overall (max 12)

8.16

10.04

1.88 (2.05)

Score (max 100%)

68.04

83.73

15.69 (17.09)

Self-efﬁcacy:
Overall (max 6)
Score (max 100%)

3.70

4.41

0.71 (0.81)

61.71

73.61

11.90 (13.43)

3.53

3.79

0.26 (0.55)

58.90

63.19

4.29 (9.25)

KnowPain-12:
Overall (max 6)
Score (max 100%)

Note. The sample size was n = 1079.

session via Adobe Connect
(Adobe Systems, San Jose, CA).
This allowed clinician participation connection from any
Internet-connected device.
ECHO Pain and other
initiatives serving remote
communities have provided
successful educational training;
however, the large number of
participants during a single
event has been unique to this
initiative.8
Clinicians from 28 states
participated in this study. The
states were heavily skewed to the
large states with large rural areas
in the West, Southwest, and
Midwest regions, which mirror
the distribution of the AI/AN
population. The states with the
largest representation of participating clinicians included
Arizona (251), New Mexico
(154), Minnesota (128), and
Oklahoma (103). Other states
had fewer than 100 clinicians
participating. Seventy-four
percent of these clinicians
practice full time.

DISCUSSION
The collaboration between
the University of New Mexico

Pain Center, ECHO Pain, and
the IHS Telebehavioral Center
of Excellence increased clinician
knowledge and self-efﬁcacy and
improved attitudes toward pain
and opioid substance use disorder
treatment. Prelicensure pain education across many disciplines
does not instill the optimal skills
for many practicing clinicians,
who sometimes lack the
knowledge and conﬁdence to
care for patients with pain, opioid
substance use disorder, and
co-occurring mental health
conditions.9
Because the AI/AN population is at increased risk for
the nonmedical use of opioid
analgesics, with an earlier age
of onset and an increased risk
for substance use disorder in
general, we contend that clinician education is of paramount
importance for reducing drug
overdose deaths.1,10,11 The IHS
realizes the potential to educate
their clinicians by using technology to provide a multipronged approach with best
practices, virtual mandated
training, and optional weekly
IHS Pain and Addiction TeleECHO clinics that deliver casebased learning and structured
didactics. The October 2015
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presidential memorandum suggests
that the IHS is forward thinking
and committed to improving
the public health of AI/AN
throughout the United States.4
Although federal agencies
now require continuing medical
education to address the epidemic of opioid prescription and
heroin use by including best
practices pain management, only
5 states (Kentucky, Massachusetts,
New Mexico, Vermont, West
Virginia) require pain management and opioid education
for their prescribing clinicians.12
It is vital that evidenced-based
pain education be included with
opioid training so that clinicians
can increase their knowledge and
conﬁdence in caring for patients
with pain and substance use
disorders.
Over the next 2 years, we will
continue to monitor AI/AN
opioid prescription and death
rates to ensure that chronic pain is
being managed safely and effectively. Best practice pain management education can provide
clinicians with the skills and
conﬁdence to care for both patients suffering with chronic pain
and those who may be at risk for
opioid substance use
disorder.
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